Please select the option that best describes you:
How do you manage immunotherapy-induced myasthenia gravis?
Answer from: at Academic Institution
My go-to algorithm is well-represented in the paper by Dr. @Adeel Zubair et al.
Zubair et al., PMID 36439604
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
NCCN "Management of Immunotherapy-Related Toxicities" has a useful 'cheat sheet' as a quick reference for the overnight call.